Rivastigmine

Details

Files

Generic Name:

Rivastigmine

Project Status:

Complete

Therapeutic Area:

Dementia (Alzheimer's type)

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Exelon Patch

Project Line:

Reimbursement Review

Project Number:

SR0123-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Dementia (Alzheimer's type)

Recommendation Type:

Do not list

Final Recommendation:

July 23, 2008

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 21, 2007